Monthly Archives: March 2017

• 

Patients have routine access to more cancer drugs as prices drop, according to NICE

By Sharon Kell|2017-03-06T10:19:49+00:006 Mar 2017|Drug treatments|

The National Institute for Health and Care Excellence (NICE) reported [...]

Read More

Comments Off on Patients have routine access to more cancer drugs as prices drop, according to NICE

• 

Cabozantinib plus nivolumab phase 3 clinical trial in first-line kidney cancer

By Sharon Kell|2017-03-02T15:31:31+00:002 Mar 2017|Drug treatments|

Exelixis and Bristol-Myers Squibb (BMS) have announced a clinical development [...]

Read More

Comments Off on Cabozantinib plus nivolumab phase 3 clinical trial in first-line kidney cancer

• 

Office for National Statistics releases cancer diagnoses figures for 2015

By Sharon Kell|2017-03-02T14:52:05+00:002 Mar 2017|Cancer news|

The Office for National Statistics (ONS) have released figures for [...]

Read More

Comments Off on Office for National Statistics releases cancer diagnoses figures for 2015

• 

Researchers recommend 10 portions of fruit and veg a day to prevent an early death

By Sharon Kell|2017-03-02T14:43:30+00:002 Mar 2017|Cancer news|

Researchers from Imperial College London have said that, although eating [...]

Read More

Comments Off on Researchers recommend 10 portions of fruit and veg a day to prevent an early death

• 

Second issue of the KCSN newsletter for 2017 is available to download now

By Sharon Kell|2017-03-01T13:58:05+00:001 Mar 2017|Cancer news|

The second issue for 2017 of the KCSN newsletter is [...]

Read More

Comments Off on Second issue of the KCSN newsletter for 2017 is available to download now